Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lung Neoplasms × Analgesics, Opioid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 5 Agnosia 5 Cancer Pain 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Supratentorial Neoplasms 1 Postoperative Cognitive Complications 1 Pain, Postoperative 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Chronic Pain 1

Interventions

Carboplatin 278 Cisplatin 208 Radiotherapy 174 Paclitaxel 164 Pemetrexed 153 Docetaxel 143 Gemcitabine 133 pembrolizumab 117 Erlotinib Hydrochloride 91 Etoposide 84 Magnetic Resonance Spectroscopy 80 Bevacizumab 71 Specimen Handling 63 Radiosurgery 63 durvalumab 60 Nivolumab 60 Vinorelbine 49 osimertinib 44 Gefitinib 41 Drug Therapy 39 Irinotecan 36 Topotecan 35 atezolizumab 34 Cyclophosphamide 34 Radiation 33 Standard of Care 32 Biopsy 32 Cetuximab 30 Blood Specimen Collection 29 Immunoglobulin G 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02359175 2023-06-27

SEAVATS

Odense University Hospital

Phase 4 Completed

Lung Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡